Master Degrees in the Fort Worth in the USA 2021

Faculty members are engaged in various aspects of biochemical, biophysical, molecular, and cancer research. The specific research interests of faculty cover a wide range of topics, including signal transduction, post-translational protein modification in health and disease, protein structure and function, protein-ligand and protein-protein interactions, metabolism, molecular carcinogenesis, tumor immunology, stem cell biology, tumor invasion and metastasis, tumor microenvironment, cancer therapeutics, drug resistance, drug metabolism, drug delivery, drug discovery, nanotechnology/imaging, epigenetic effects on cancer risks, alternative medicine therapies of cancer, disorders of lipid metabolism in atherosclerosis, lipoprotein metabolism and biophysics of muscle contraction. The interdisciplinary research also includes investigation of the link between cancer with other disorders, such as aging & Alzheimer’s disease, HIV, and ocular diseases. Research projects employ state-of-the-art molecular, cellular, and biochemical techniques that include genomics, proteomics, mass spectrometry, protein crystallography, molecular cloning, gene targeting, FACS analysis, advanced fluorescence spectroscopy, optical imaging, and advanced molecular technology for the detection of genetic variation between normal and cancer cells. Students may choose faculty advisors according to their research interests. During the first year, students will acquire sufficient background in biomedical sciences, including biochemistry, molecular biology, cell biology, pharmacology, microbiology, and immunology. The students will have the opportunity to rotate in research laboratories prior to selecting their mentors. Students will take two discipline-specific courses as well as additional elective courses based on their needs and interests. MS students are expected to graduate in approximately two years, whereas Ph.D. students usually require five years to complete the degree. -

Clinical research involves the testing and determining the safety and efficacy of new unapproved products, including pharmaceuticals, devices, and biologics in human subjects. Clinical trials in humans (volunteers and patients) are required before marketing approval by regulatory authorities such as the U.S. Food and Drug Administration (FDA). The law that governs clinical research is spelled out in Chapter 21 of the Code of Federal Regulations (CFR). In addition to requiring and legislating clinical trials, regulatory authorities define the standards by which clinical trials are to be conducted. These standards are known as Good Clinical Practices (GCPs). In-depth knowledge of the CFR and GCP guidelines as well as international guidelines specifically as they relate to protection of human rights, prevention and detection of fraud, and the use of sound scientific principles, is a fundamental requirement for clinical research professionals. These individuals are key personnel involved in the conduct of clinical trials which, in turn, are pivotal in getting new products approved and on the market. The master’s program in Clinical Research Management provides a strong foundation upon which to build or advance a career. The rigorous curriculum focuses on providing students a broad-based view of the biomedical sciences, as well as in-depth knowledge of regulatory requirements (CFR, GCP), ethical issues, and both the medical writing and administrative skills necessary to conduct clinical research. As part of the program, all students will complete an internship practicum in clinical studies and use this experience to write the internship practicum report pursuant to receiving the Master of Science (MS) degree. The average time to complete the degree is eighteen months with full-time enrollment. -